Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg, Karl; Komajda, Michel; Böhm, Michael; Borer, Jeffrey S; Ford, Ian; Dubost-Brama, Ariane; Lerebours, Guy; Tavazzi, Luigi

Swedberg, Karl; Komajda, Michel; Böhm, Michael; Borer, Jeffrey S; Ford, Ian; Dubost-Brama, Ariane; Lerebours, Guy; Tavazzi, Luigi.

Affiliation

Swedberg K; Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. karl.swedberg@gu.se

Lancet ; 376(9744): 875-85, 2010 Sep 11.

Article in En | MEDLINE | ID: mdl-20801500

Subject(s)

Benzazepines/therapeutic use; Cardiovascular Agents/therapeutic use; Heart Failure/drug therapy; Heart Failure/mortality; Heart Rate/drug effects; Sinoatrial Node/drug effects; Adult; Aged; Benzazepines/administration & dosage; Benzazepines/adverse effects; Cardiovascular Agents/administration & dosage; Cardiovascular Agents/adverse effects; Chronic Disease; Double-Blind Method; Electrocardiography; Female; Heart Failure/complications; Heart Failure/physiopathology; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Severity of Illness Index; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sinoatrial Node / Benzazepines / Cardiovascular Agents / Heart Failure / Heart Rate Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2010 Document type: Article Affiliation country: Sweden Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google